You are viewing: UAE Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The UAE Long Read Sequencing Market was valued at $5.7 Million in 2024 and projected to reach to $20.5 Million by 2029, representing a compound annual growth rate of 29.0%. The UAE long read sequencing market is poised for significant expansion through 2029, driven by substantial government investments in healthcare infrastructure and genomic research capabilities.

UAE Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UAE Long Read Sequencing Market Trends and Insights

  • The UAE's strategic investments in genomic research infrastructure and healthcare innovation are driving adoption of advanced sequencing technologies across diagnostic and research institutions.
  • The UAE's position as a regional healthcare hub, combined with government support for precision medicine initiatives, positions the market for accelerated growth through 2029. In 2024, the UAE long read sequencing market reflects early-stage but rapidly maturing adoption driven by academic medical centers and specialized diagnostic laboratories.
  • The UAE's healthcare sector is increasingly recognizing long read sequencing's advantages in resolving complex genomic structures and detecting structural variants.
  • By 2029, the UAE market is expected to benefit from declining technology costs, expanded clinical applications, and growing demand for personalized medicine solutions across the region..

Key Market Statistics

  • CAGR (2024-2029) 29.0% CAGR
  • Market Size, 2024 ~USD 5.7 Million
  • Forecast, 2029 ~USD 20.5 Million
  • Country UAE

UAE Long Read Sequencing Market Overview

Market Valuation Growth :

UAE's long read sequencing market valued at $5.7 million in 2024, with projected growth to $20.5 million by 2029, representing a 29% CAGR and outpacing many regional markets.

Regional Healthcare Hub Status :

UAE's positioning as a leading Middle Eastern healthcare innovation center drives adoption of advanced sequencing technologies across diagnostic centers, research institutions, and precision medicine facilities.

Government Investment in Genomics :

Strategic government initiatives and funding for genomic research infrastructure, including support for precision medicine programs and biotech development, accelerate long read sequencing technology deployment.

Clinical and Research Applications :

Increasing adoption across UAE's diagnostic laboratories, academic medical centers, and pharmaceutical research organizations for rare disease identification, cancer genomics, and personalized treatment planning.

UAE Long Read Sequencing Market Dynamics

  • The nation's commitment to becoming a regional biotech and precision medicine leader creates favorable conditions for technology adoption.
  • Healthcare institutions across Dubai, Abu Dhabi, and other emirates are increasingly integrating long read sequencing into diagnostic workflows and research programs. Key growth catalysts include rising prevalence of genetic disorders, expanding pharmaceutical R&D activities, and partnerships between UAE institutions and global genomics leaders.
  • The market will benefit from improved reimbursement policies, growing clinical validation of long read applications, and increased awareness among healthcare providers.
  • Competitive pricing and localized service offerings will further accelerate market penetration across public and private healthcare sectors..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • The UAE long read sequencing market is projected to grow from $5.7M (2024) to $20.5M (2029), representing a 29% CAGR.
    • The UAE's healthcare infrastructure investments and precision medicine initiatives are primary catalysts for market expansion.
    • The UAE market benefits from regional positioning as a medical innovation hub attracting international research collaborations.
    • By 2029, the UAE long read sequencing market will be driven by clinical adoption, cost reduction, and expanded diagnostic applications.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    UAE Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    UAE: LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTE33.94.86.17.79.912.917.229
    HOSPITALS, CLINICS, AND DIAGNOSTIC LABS11.31.622.63.34.35.829.6
    OTHER END USER0.50.60.80.91.11.41.82.324.1
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES1.41.82.32.93.74.76.18.128.8
    TOTAL5.97.79.511.915.119.42533.428.7

    Target Audience

    • Sequencing Technology Manufacturers : Require UAE market data to assess demand for long read platforms, identify key institutional buyers, and develop region-specific product strategies and pricing models.
    • Diagnostic Laboratory Operators : Need market insights to evaluate technology investment ROI, benchmark against competitors, and understand clinical adoption trends and reimbursement opportunities in UAE.
    • Healthcare Investment Firms : Seek comprehensive market analysis to identify investment opportunities in UAE genomics startups, diagnostic centers, and precision medicine initiatives with growth potential.
    • Pharmaceutical and Biotech Companies : Require UAE-specific data on genomic research capabilities and institutional partnerships to plan R&D collaborations, clinical trial recruitment, and precision medicine program development.
    • Healthcare Policy and Government Bodies : Need market intelligence to inform healthcare strategy, genomics infrastructure planning, and regulatory framework development supporting precision medicine adoption across UAE.

    Reasons to Buy this Report

    • Market Entry Strategy : Comprehensive UAE-specific data enables informed market entry decisions, competitive positioning, and localized go-to-market strategies for sequencing technology providers and service providers.
    • Investment Decision Support : Detailed market sizing, growth projections, and trend analysis provide venture capital, private equity, and corporate investors with validated data for UAE genomics and precision medicine investments.
    • Competitive Intelligence : In-depth insights into UAE's healthcare institution landscape, adoption patterns, and key players enable competitive benchmarking and identification of partnership and acquisition opportunities.
    • Regulatory and Policy Insights : Understanding of UAE's healthcare regulatory environment, government initiatives, and reimbursement frameworks critical for compliance planning and stakeholder engagement strategies.
    • Customer Targeting : Segmented analysis of UAE diagnostic centers, research institutions, and pharmaceutical companies enables precise customer identification and tailored value proposition development for sales and marketing teams.

    Frequently asked questions

    What is the current size of the UAE long read sequencing market?

    The UAE long read sequencing market was valued at $5.7 million in 2024.

    What is the projected market size for the UAE by 2029?

    The UAE long read sequencing market is forecast to reach $20.5 million by 2029.

    What is the CAGR for the UAE long read sequencing market?

    The UAE long read sequencing market is expected to grow at a compound annual growth rate of 29% from 2024 to 2029.

    What factors are driving growth in the UAE long read sequencing market?

    Growth in the UAE market is driven by government investments in genomic research, precision medicine initiatives, declining technology costs, and expanding clinical applications in diagnostic laboratories.

    Which sectors are adopting long read sequencing in the UAE?

    The UAE's academic medical centers, specialized diagnostic laboratories, and research institutions are leading adopters of long read sequencing technology.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status